Hyper-lucent one lung syndrome - MacLeod syndrome: A rare case associated with COPD

---

Case Report

Author Details : Vinay Mohan, Bharat Bhushan, Sunita Devi, Ritu Puneet Kaur, Arjun Bhatnager

Volume : 2, Issue : 2, Year : 2017

Article Page : 60-64

Suggest article by email

Get Permission

---

Abstract

Hyper-lucent one sided lung syndrome or Swyer James Macleod syndrome is uncommon entity. Sometimes it might be associated after bronchiolitis obliterans infections occurring during earlier part of life. Resultant Pulmonary hypo perfusion because of incomplete or absent development of the pulmonary arteries resulting in a reduced amount of blood flow in lungs is a characteristic feature of it. Typically, this disorder is diagnosed incidentally in recurrent childhood respiratory infections evaluations or occasionally it may follow a silent course only to be diagnosed at adulthood. Here, we report a case in a 70-year-old male person with Swyer James Macleod syndrome incidentally diagnosed while workup for a COPD differentials who presented with dyspnoea on exertion, cough with expectoration. Hence this case highlights the importance of computerized tomography in the diagnostic workup of a case of hyper-lucent lung. All smokers presented with breathlessness and huperlucent lungs may not always be an emphysematous COPD cases. It could be a case of COPD with SJMS though extremely rare. Hence should be thoroughly investigated.

Keywords: Bronchiolitis obliterans; Pulmonary artery abnormalities, Swyer-James/MacLeod syndrome; Unilateral hyper-lucent lung

How to cite : Mohan V, Bhushan B, Devi S, Kaur R P, Bhatnager A, Hyper-lucent one lung syndrome - MacLeod syndrome: A rare case associated with COPD. IP Indian J Immunol Respir Med 2017;2(2):60-64

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.